McGill University Health Centre, Montreal (Canada)
Member of:
Abhinav Sharma is an Assistant Professor at McGill University in the Department of Medicine, Division of Cardiology. He completed his medical school and internal medicine from McMaster University and his cardiology fellowship from the University of Alberta. He started his PhD in epidemiology with a thesis focusing on the intersection of diabetes and heart failure (defending summer/fall 2019). He went to Duke University to complete a cardiovascular research fellowship (05/2015-05/2017). Following this, he went to Stanford University and completed an advanced heart failure and cardiac transplantation fellowship (06/2017-05/2018). He continued as a Postgraduate Visiting Scholar at Stanford University in digital health (06/2018-01/2019). He is the recipient of the FRQ-S Chercheur-Boursier Clinicien award (Junior 1).
Association of actigraphy endpoints and 6-minute walk distance in patients with heart failure: a pilot study from the Courtois Cardiovascular Signature Program
Event:
Heart Failure 2024
Topic:
Remote Patient Monitoring and Telehealth
Session:
ePosters in e-Cardiology/digital health 3
Timing of statistical benefit of canagliflozin in patients with type 2 diabetes for cardiovascular and heart failure outcomes: insights from the CANVAS Program and CREDENCE trial
Effects of canagliflozin on cardiovascular and kidney outcomes and mortality in primary and secondary cardiovascular prevention: pooled analysis from the CANVAS program and CREDENCE trial
Event:
ESC Congress 2022
Topic:
Secondary Prevention
Session:
Optimal risk factor therapy in high risk patients
Impact of changes in weight and haematocrit on the reduction in systolic office and ambulatory blood pressure with empagliflozin in patients with type 2 diabetes
Event:
ESC Congress 2021 - The Digital Experience
Topic:
Comorbidities
Session:
Congress committee e-posters choice in heart failure